;PMID: 8961670
;source_file_773.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..41] = [t:0..41]
;1)sentence:[e:46..133] = [t:46..133]
;2)section:[e:137..204] = [t:137..204]
;3)section:[e:208..288] = [t:208..288]
;4)sentence:[e:292..380] = [t:292..380]
;5)sentence:[e:381..619] = [t:381..619]
;6)sentence:[e:620..708] = [t:620..708]
;7)sentence:[e:709..748] = [t:709..748]
;8)sentence:[e:749..910] = [t:749..910]
;9)sentence:[e:911..1132] = [t:911..1132]
;10)section:[e:1136..1180] = [t:1136..1180]

;section 0 Span:0..41
;J Formos Med Assoc  1996 Oct;95(10):741-5
(SEC
  (FRAG (NNP:[0..1] J) (NNP:[2..8] Formos) (NNP:[9..12] Med)
        (NNP:[13..18] Assoc) (CD:[20..24] 1996) (IN:[25..32] Oct;95-LRB-)
        (CD:[32..34] 10) (-RRB-:[34..35] -RRB-) (CD:[35..39] :741)
        (::[39..40] -) (CD:[40..41] 5)))

;sentence 1 Span:46..133
;Detection of k-ras point mutations in codons 12 and 13 in non-small cell lung
; cancers.
;[59..64]:gene-rna:"k-ras"
;[65..80]:variation-type:"point mutations"
;[84..93]:variation-location:"codons 12"
;[84..90]...[98..100]:variation-location:"codons"..."13"
;[104..132]:malignancy:"non-small cell lung  cancers"
(SENT
  (NP-HLN
    (NP (NN:[46..55] Detection))
    (PP (IN:[56..58] of)
      (NP (NN:[59..64] k-ras)
         (NN:[65..70] point) (NNS:[71..80] mutations)))
    (PP-LOC (IN:[81..83] in)
      (NP
        (NP
          (NML-1 (DT:[84..90] codons))
          (CD:[91..93] 12))
        (CC:[94..97] and)
        (NP
          (NML-1 (-NONE-:[97..97] *P*))
          (CD:[98..100] 13))))
    (PP-LOC (IN:[101..103] in)
      (NP
        (NML (AFX:[104..107] non) (HYPH:[107..108] -) (JJ:[108..113] small)
             (NN:[114..118] cell))
        (NN:[119..123] lung) (NNS:[125..132] cancers)))
    (.:[132..133] .)))

;section 2 Span:137..204
;Hsu NY, Chen CY, Wu CH, Liu TJ, Kwan PC, Hsu CP, Hsia JY, Chang WT.
(SEC
  (FRAG (NNP:[137..140] Hsu) (NNP:[141..143] NY) (,:[143..144] ,)
        (NNP:[145..149] Chen) (NNP:[150..152] CY) (,:[152..153] ,)
        (NNP:[154..156] Wu) (NNP:[157..159] CH) (,:[159..160] ,)
        (NNP:[161..164] Liu) (NNP:[165..167] TJ) (,:[167..168] ,)
        (NNP:[169..173] Kwan) (NNP:[174..176] PC) (,:[176..177] ,)
        (NNP:[178..181] Hsu) (NNP:[182..184] CP) (,:[184..185] ,)
        (NNP:[186..190] Hsia) (NNP:[191..193] JY) (,:[193..194] ,)
        (NNP:[195..200] Chang) (NNP:[201..204] WT.)))

;section 3 Span:208..288
;Department of Medical Research, Taichung veterans General Hospital, Taiwan,
;ROC.
(SEC
  (FRAG (NNP:[208..218] Department) (IN:[219..221] of) (NNP:[222..229] Medical)
        (NNP:[230..238] Research) (,:[238..239] ,) (NNP:[240..248] Taichung)
        (NNS:[249..257] veterans) (NNP:[258..265] General)
        (NNP:[266..274] Hospital) (,:[274..275] ,) (NNP:[276..282] Taiwan)
        (,:[282..283] ,) (NNP:[284..288] ROC.)))

;sentence 4 Span:292..380
;Point mutations of the K-ras gene have been reported in a wide variety of
;human  tumors.
;[292..307]:variation-type:"Point mutations"
;[315..320]:gene-rna:"K-ras"
(SENT
  (S
    (NP-SBJ-1
      (NP (NN:[292..297] Point) (NNS:[298..307] mutations))
      (PP (IN:[308..310] of)
        (NP (DT:[311..314] the) (NN:[315..320] K-ras) (NN:[321..325] gene))))
    (VP (VBP:[326..330] have)
      (VP (VBN:[331..335] been)
        (VP (VBN:[336..344] reported)
          (NP-1 (-NONE-:[344..344] *))
          (PP-LOC (IN:[345..347] in)
            (NP
              (NP (DT:[348..349] a) (JJ:[350..354] wide) (NN:[355..362] variety))
              (PP (IN:[363..365] of)
                (NP (JJ:[366..371] human) (NNS:[373..379] tumors))))))))
    (.:[379..380] .)))

;sentence 5 Span:381..619
;By using polymerase chain reaction followed by direct DNA sequencing, we 
;screened for point mutations at codons 12 and 13 of the K-ras gene in
;specimens  obtained from fresh frozen tumors in 38 patients with non-small
;cell lung  cancers.
;[390..400]:gene-protein:"polymerase"
;[468..483]:variation-type:"point mutations"
;[487..496]:variation-location:"codons 12"
;[487..493]...[501..503]:variation-location:"codons"..."13"
;[511..516]:gene-rna:"K-ras"
;[563..569]:malignancy:"tumors"
;[590..618]:malignancy:"non-small cell lung  cancers"
(SENT
  (S
    (PP-MNR (IN:[381..383] By)
      (S-NOM
        (NP-SBJ (-NONE-:[383..383] *))
        (VP (VBG:[384..389] using)
          (NP
            (NP (NN:[390..400] polymerase) (NN:[401..406] chain)
                (NN:[407..415] reaction))
            (VP (VBN:[416..424] followed)
              (NP (-NONE-:[424..424] *))
              (PP (IN:[425..427] by)
                (NP-LGS (JJ:[428..434] direct) (NN:[435..438] DNA)
                        (NN:[439..449] sequencing))))))))
    (,:[449..450] ,)
    (NP-SBJ (PRP:[451..453] we))
    (VP (VBD:[455..463] screened)
      (PP (IN:[464..467] for)
        (NP
          (NP (NN:[468..473] point) (NNS:[474..483] mutations))
          (PP-LOC (IN:[484..486] at)
            (NP
              (NP
                (NP
                  (NML-1 (NNS:[487..493] codons))
                  (CD:[494..496] 12))
                (CC:[497..500] and)
                (NP
                  (NML-1 (-NONE-:[500..500] *P*))
                  (CD:[501..503] 13)))
              (PP (IN:[504..506] of)
                (NP (DT:[507..510] the) (NN:[511..516] K-ras)
                    (NN:[517..521] gene)))))))
      (PP-LOC (IN:[522..524] in)
        (NP
          (NP (NNS:[525..534] specimens))
          (VP (VBN:[536..544] obtained)
            (NP (-NONE-:[544..544] *))
            (PP (IN:[545..549] from)
              (NP (JJ:[550..555] fresh) (JJ:[556..562] frozen)
                  (NNS:[563..569] tumors)))
            (PP-LOC (IN:[570..572] in)
              (NP
                (NP (CD:[573..575] 38) (NNS:[576..584] patients))
                (PP (IN:[585..589] with)
                  (NP
                    (NML (AFX:[590..593] non) (HYPH:[593..594] -)
                         (JJ:[594..599] small) (NN:[600..604] cell))
                    (NN:[605..609] lung) (NNS:[611..618] cancers)))))))))
    (.:[618..619] .)))

;sentence 6 Span:620..708
;Point mutations were detected in two of 38 (5.3%) resected non-small  cell
;lung cancers.
;[620..635]:variation-type:"Point mutations"
;[679..707]:malignancy:"non-small  cell lung cancers"
(SENT
  (S
    (NP-SBJ-1 (NN:[620..625] Point) (NNS:[626..635] mutations))
    (VP (VBD:[636..640] were)
      (VP (VBN:[641..649] detected)
        (NP-1 (-NONE-:[649..649] *))
        (PP-LOC (IN:[650..652] in)
          (NP
            (NP (CD:[653..656] two))
            (PP (IN:[657..659] of)
              (NP (CD:[660..662] 38)
                (PRN (-LRB-:[663..664] -LRB-)
                  (NP (CD:[664..667] 5.3) (NN:[667..668] %))
                  (-RRB-:[668..669] -RRB-))
                (JJ:[670..678] resected)
                
                (NML (AFX:[679..682] non) (HYPH:[682..683] -)
                     (JJ:[683..688] small) (NN:[690..694] cell))
                (NN:[695..699] lung) (NNS:[700..707] cancers)))))))
    (.:[707..708] .)))

;sentence 7 Span:709..748
;Both of them were G to T transversions.
;[727..728]:variation-state-original:"G"
;[732..733]:variation-state-altered:"T"
;[734..747]:variation-type:"transversions"
(SENT
  (S
    (NP-SBJ
      (NP (DT:[709..713] Both))
      (PP (IN:[714..716] of)
        (NP (PRP:[717..721] them))))
    (VP (VBD:[722..726] were)
      (NP-PRD
        (NML
          (NML (NN:[727..728] G))
          (PP (TO:[729..731] to)
            (NP (NN:[732..733] T))))
        (NNS:[734..747] transversions)))
    (.:[747..748] .)))

;sentence 8 Span:749..910
;One patient was found  to have a K-ras codon 13 point mutation (GGC to TGC,
;gly to cys), while the  other had a codon 12 point mutation (GGT to GTT, gly
;to val).
;[782..787]:gene-rna:"K-ras"
;[788..796]:variation-location:"codon 13"
;[797..811]:variation-type:"point mutation"
;[813..816]:variation-state-original:"GGC"
;[820..823]:variation-state-altered:"TGC"
;[825..828]:variation-state-original:"gly"
;[832..836]:variation-state-altered:"cys)"
;[861..869]:variation-location:"codon 12"
;[870..884]:variation-type:"point mutation"
;[886..889]:variation-state-original:"GGT"
;[893..896]:variation-state-altered:"GTT"
;[898..901]:variation-state-original:"gly"
;[905..908]:variation-state-altered:"val"
(SENT
  (S
    (NP-SBJ-1 (CD:[749..752] One) (NN:[753..760] patient))
    (VP (VBD:[761..764] was)
      (VP (VBN:[765..770] found)
        (S
          (NP-SBJ-1 (-NONE-:[770..770] *))
          (VP (TO:[772..774] to)
            (VP (VB:[775..779] have)
              (NP (DT:[780..781] a) (NN:[782..787] K-ras)
                (NML (NN:[788..793] codon) (CD:[794..796] 13))
                 (NN:[797..802] point) (NN:[803..811] mutation)
                (PRN (-LRB-:[812..813] -LRB-)
                  (NP
                    (NP
                      (NP (NN:[813..816] GGC))
                      (PP (TO:[817..819] to)
                        (NP (NN:[820..823] TGC))))
                    (,:[823..824] ,)
                    (NP
                      (NP (NN:[825..828] gly))
                      (PP (TO:[829..831] to)
                        (NP (NN:[832..835] cys)))))
                  (-RRB-:[835..836] -RRB-))))))
        (,:[836..837] ,)
        (SBAR-ADV (IN:[838..843] while)
          (S
            (NP-SBJ (DT:[844..847] the) (NN:[849..854] other))
            (VP (VBD:[855..858] had)
              (NP (DT:[859..860] a)
                (NML (NN:[861..866] codon) (CD:[867..869] 12))
                 (NN:[870..875] point) (NN:[876..884] mutation)
                (PRN (-LRB-:[885..886] -LRB-)
                  (NP
                    (NP
                      (NP (NN:[886..889] GGT))
                      (PP (TO:[890..892] to)
                        (NP (NN:[893..896] GTT))))
                    (,:[896..897] ,)
                    (NP
                      (NP (NN:[898..901] gly))
                      (PP (TO:[902..904] to)
                        (NP (NN:[905..908] val)))))
                  (-RRB-:[908..909] -RRB-))))))))
    (.:[909..910] .)))

;sentence 9 Span:911..1132
;Based on the  limited numbers in this study, we found that the frequency of
;K-ras point  mutations in codons 12 and 13 among Asian patients with lung
;adenocarcinomas was  lower than that detected among Caucasian patients.
;[987..992]:gene-rna:"K-ras"
;[993..1009]:variation-type:"point  mutations"
;[1013..1022]:variation-location:"codons 12"
;[1013..1019]...[1027..1029]:variation-location:"codons"..."13"
;[1056..1076]:malignancy:"lung adenocarcinomas"
(SENT
  (S
    (S-ADV
      (NP-SBJ (-NONE-:[911..911] *))
      (VP (VBN:[911..916] Based)
        (PP-CLR (IN:[917..919] on)
          (NP
            (NP (DT:[920..923] the) (JJ:[925..932] limited)
                (NNS:[933..940] numbers))
            (PP (IN:[941..943] in)
              (NP (DT:[944..948] this) (NN:[949..954] study)))))))
    (,:[954..955] ,)
    (NP-SBJ (PRP:[956..958] we))
    (VP (VBD:[959..964] found)
      (SBAR (IN:[965..969] that)
        (S
          (NP-SBJ
            (NP (DT:[970..973] the) (NN:[974..983] frequency))
            (PP (IN:[984..986] of)
              (NP (NN:[987..992] K-ras)
                 (NN:[993..998] point) (NNS:[1000..1009] mutations)))
            (PP-LOC (IN:[1010..1012] in)
              (NP
                (NP
                  (NML-1 (NNS:[1013..1019] codons))
                  (CD:[1020..1022] 12))
                (CC:[1023..1026] and)
                (NP
                  (NML-1 (-NONE-:[1026..1026] *P*))
                  (CD:[1027..1029] 13)))))
          (PP (IN:[1030..1035] among)
            (NP
              (NP (JJ:[1036..1041] Asian) (NNS:[1042..1050] patients))
              (PP (IN:[1051..1055] with)
                (NP (NN:[1056..1060] lung) (NNS:[1061..1076] adenocarcinomas)))))
          (VP (VBD:[1077..1080] was)
            (ADJP-PRD
              (ADJP (JJR:[1082..1087] lower))
              (PP (IN:[1088..1092] than)
                (NP
                  (NP (DT:[1093..1097] that))
                  (VP (VBN:[1098..1106] detected)
                    (NP (-NONE-:[1106..1106] *))
                    (PP (IN:[1107..1112] among)
                      (NP (JJ:[1113..1122] Caucasian)
                          (NNS:[1123..1131] patients)))))))))))
    (.:[1131..1132] .)))

;section 10 Span:1136..1180
;PMID: 8961670 [PubMed - indexed for MEDLINE]
(SEC
  (FRAG (NNP:[1136..1140] PMID) (::[1140..1141] :) (CD:[1142..1149] 8961670)
        (NN:[1150..1151] -LSB-) (NNP:[1151..1157] PubMed) (::[1158..1159] -)
        (NN:[1160..1167] indexed) (IN:[1168..1171] for)
        (NNP:[1172..1180] MEDLINE-RSB-)))
